Is Bristol Myers Stock A Buy As Opdivo Faces An FDA Hurdle In April?...buy point 68.44 | BMY Message Board Posts


Bristol-Myers Squibb Co.

  BMY website

BMY   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  6892 of 7919  at  4/26/2021 2:21:11 PM  by

buylowalways


Is Bristol Myers Stock A Buy As Opdivo Faces An FDA Hurdle In April?...buy point 68.44

Bristol Myers Squibb (BMY) is preparing to defend its blockbuster drug Opdivo in liver cancer patients — but BMY stock has ticked up this year.

Often times investors first ask themselves which stocks they should buy,

Bristol Myers Squibb (BMY) is preparing to defend its blockbuster drug Opdivo in liver cancer patients — but BMY stock has ticked up this year.



     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0  
   Views: 0 []
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


Financial Market Data provided by
.
Loading...